| 721828 |
FRONTIERS IN ONCOLOGY |
MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity In Vivo |
2021-07-30 |
10.3389/fonc.2021.678343 |
Sargiacomo Camillo, Stonehouse Sophie, Moftakhar Zahra, Sotgia Federica, Lisanti Michael P. |
| 721827 |
FRONTIERS IN ONCOLOGY |
Mechanisms and Implications of CDK4/6 Inhibitors for the Treatment of NSCLC |
2021-07-30 |
10.3389/fonc.2021.676041 |
Zhang Jinmeng, Xu Dayu, Zhou Yue, Zhu Zhengfei, Yang Xi |
| 721826 |
FRONTIERS IN ONCOLOGY |
Colorectal Cancer Screening Prevalence and Adherence for the Cancer Prevention Project of Philadelphia (CAP3) Participants Who Self-Identify as Black |
2021-07-30 |
10.3389/fonc.2021.690718 |
Blackman Elizabeth L., Ragin Camille, Jones Resa M. |
| 721825 |
FRONTIERS IN ONCOLOGY |
Editorial: Bone Metastases |
2021-07-30 |
10.3389/fonc.2021.741515 |
Valenti Maria Teresa, Mottes Monica, Dalle Carbonare Luca, Feron Olivier |
| 721824 |
FRONTIERS IN ONCOLOGY |
Intensive Debulking Chemotherapy Improves the Short-Term and Long-Term Efficacy of Anti-CD19-CAR-T in Refractory/Relapsed DLBCL With High Tumor Bulk |
2021-07-30 |
10.3389/fonc.2021.706087 |
Lyu Cuicui, Cui Rui, Wang Jia, Mou Nan, Jiang Yanyu, Li Wei, Deng Qi |
| 721823 |
FRONTIERS IN ONCOLOGY |
N6-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling |
2021-07-30 |
10.3389/fonc.2021.704543 |
Liu Zhicheng, Li Shanshan, Huang Shan, Wang Tao, Liu Zhicheng |
| 721822 |
FRONTIERS IN ONCOLOGY |
Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study |
2021-07-30 |
10.3389/fonc.2021.716741 |
Wang Zhixian, Yin Yisheng, Wang Jing, Zhu Yunpeng, Li Xing, Zeng Xiaoyong |
| 721821 |
FRONTIERS IN ONCOLOGY |
The Clinical Experiences of Urine Metabolomics of Genitourinary Urothelial Cancer in a Tertiary Hospital in Taiwan |
2021-07-30 |
10.3389/fonc.2021.680910 |
Juang Horng-Heng, Chen Shao-Ming, Lin Gigin, Chiang Meng-Han, Hou Chen-Pang, Lin Yu-Hsiang, Yang Pei-Shan, Chang Phei-Lang, Chen Chien-lun, Lin Kuo-Yen, Tsui Ke-Hung |
| 721820 |
FRONTIERS IN ONCOLOGY |
Tumor Growth in the High Frequency Medulloblastoma Mouse Model Ptch1+/−/Tis21KO Has a Specific Activation Signature of the PI3K/AKT/mTOR Pathway and Is Counteracted by the PI3K Inhibitor MEN1611 |
2021-07-30 |
10.3389/fonc.2021.692053 |
Ceccarelli Manuela, D’Andrea Giorgio, Micheli Laura, Gentile Giulia, Cavallaro Sebastiano, Merlino Giuseppe, Papoff Giuliana, Tirone Felice |
| 721819 |
FRONTIERS IN ONCOLOGY |
Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer |
2021-07-30 |
10.3389/fonc.2021.624837 |
Hua Qing, Li Tianjiao, Liu Yixuan, Shen Xuefang, Zhu Xiaoyan, Xu Pingbo |
